TY - JOUR
T1 - A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators
AU - Duff, Elsie
AU - Fehr, Cindy
AU - Shams, Shahid
AU - Wintoniw, Steven
AU - Devenney, Ashley
AU - Ashfield, Diana
AU - O'Rourke, Tammy
N1 - Publisher Copyright:
© 2024
PY - 2024/4
Y1 - 2024/4
N2 - Canadians face steep barriers to access treatment for opioid use disorder, including limitations in entry points due to clinical capacity issues. Nurse practitioners (NPs) are well-positioned to ease some of the backlog, given that they prescribe all classes of drugs, including opioid agonist therapy (OAT) medication. In this study, we conducted a cross-sectional online survey of NP respondents (N = 114) in Alberta, Saskatchewan, and Manitoba in 2021 of OAT practice, with a focus on NPs as a point-of-care access for patients with substance dependence. Overall, this research adds to the general knowledge of the various barriers and facilitators to NP OAT prescribing.
AB - Canadians face steep barriers to access treatment for opioid use disorder, including limitations in entry points due to clinical capacity issues. Nurse practitioners (NPs) are well-positioned to ease some of the backlog, given that they prescribe all classes of drugs, including opioid agonist therapy (OAT) medication. In this study, we conducted a cross-sectional online survey of NP respondents (N = 114) in Alberta, Saskatchewan, and Manitoba in 2021 of OAT practice, with a focus on NPs as a point-of-care access for patients with substance dependence. Overall, this research adds to the general knowledge of the various barriers and facilitators to NP OAT prescribing.
KW - addiction
KW - Canada
KW - nurse practitioners
KW - opioid agonist therapy
KW - substance use
UR - http://www.scopus.com/inward/record.url?scp=85183480538&partnerID=8YFLogxK
U2 - 10.1016/j.nurpra.2023.104914
DO - 10.1016/j.nurpra.2023.104914
M3 - Journal Article
AN - SCOPUS:85183480538
SN - 1555-4155
VL - 20
JO - Journal for Nurse Practitioners
JF - Journal for Nurse Practitioners
IS - 4
M1 - 104914
ER -